Linagliptin contains not less than 98% and not more than 102.0% of C25H28N8O2, calculated on anhydrous basis.

共有 1 個藥物證書使用此成份

L-挪葡汀
Linagliptin

• 申請商: 和聯生醫股份有限公司
• 適應症: 降血糖藥。
• 發證日期: 2022-10-28